Global contrast media market is anticipated to grow at a considerable CAGR of 6.5% during the forecast period (2024-2031). The growing demand for contrast media in the diagnosis of several diseases is a key factor driving the global market. The ongoing R&D programs and FDA approvals to identify the potential new applications of contrast media are further aiding the global market growth. For instance, in June 2023, Bayer initiated the Phase III clinical development program called QUANTI, aiming to evaluate the safety and efficacy of gadoquatrane, an investigational extracellular macrocyclic gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). Gadoquatrane is a highly stable MRI contrast agent featuring high relativity being studied to evaluate the potential of a substantially lower gadolinium (Gd) dose for patients.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/contrast-media-market

Further, in March 2023, GE HealthCare announced the completion of Phase I subject recruitment in its early clinical development program for a first-of-its-kind manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. This manganese-based agent could broaden GE HealthCare’s portfolio of MRI contrast agents available to radiologists, providing a potential alternative in light of perceived concerns relating to gadolinium retention. The macrocyclic, extra-cellular – or general-purpose – manganese-based contrast agent has comparable relativity - the ability of a contrast agent to enhance signal intensity during an MRI scan - and is expected to be diagnostically similar to current gadolinium-based contrast agents (GBCAs).

Global Contrast Media Market Report Segment

By Type

Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Barium-based Contrast Media

By Procedure

X-Ray/ Computed Tomography
Magnetic Resonance Imaging (MRI)
Ultrasound

By Indication

Cardiovascular Diseases
Oncology
Gastrointestinal Disorders
Neurological Disorders

A full report of Contrast Media Market available @ https://www.omrglobal.com/industry-reports/contrast-media-market




Contrast Media Market Report Segment by Region




North America          

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific   

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles




Braun Melsungen AG
Beijing Beilu Pharmaceutical Co. Ltd.
Borregaard
CONGRUENT PHARMACHEM PVT LTD
CR Double-Crane Pharmaceuticals Co., Ltd
DAIICHI SANKYO COMPANY, LTD.
Eisai Co., Ltd
FUJIFILM Corp.
HANA PHARM CO., LTD.
iMAX Diagnostic Imaging Limited




Reasons to Buying From us –

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

 

 

Media Contact:




Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404

Company Name: Orion Market Research